Company profile: Synsight
1.1 - Company Overview
Company description
- Provider of molecular modeling, bioinformatics, and structural biology services to accelerate research for pharmaceutical and cosmetic industries. Offerings include MT Bench microscopy-based screening of molecule effects on protein interactions, high-content phenotypic screening, AI/chemoinformatics for candidate design, a therapeutic portfolio focused on protein-RNA targets, and CRO support for protein design, diagnostic kits, and drug discovery.
Products and services
- Artificial Intelligence & Chemoinformatics: Custom-engineered deep learning models guide generation of candidate molecules by analyzing multi-scale data on efficacy, target binding in cells, and target binding at the molecular level
- High-Content Screening: High-throughput method evaluates molecule effects on specific phenotypes by observing thousands of cellular events and generating high-resolution fluorescence images
- Microtubule Bench (MT bench): Cell-based microscopy technology screens molecules, identifying and quantifying modulations of small molecules on protein-protein or protein–nucleic acid interactions within cells
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synsight
StudyKIK
HQ: United States
Website
- Description: Provider of patient recruitment and retention technology for clinical trials, connecting trial companies with volunteers and offering KIKsite for data management and communication, Virtual Visits, CarePackage integrating telemedicine and eConsent, PatientEngage+ for enrollment and engagement, and SupportHub for outreach, appointment reminders, and transportation coordination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StudyKIK company profile →
OmniComm
HQ: United States
Website
- Description: Provider of Electronic Data Capture and eClinical technologies for clinical trial organizations and the life sciences industry, including pharma, biotech, CROs, diagnostic and device firms, and academic medical centers. Offerings include TrialMaster EDC; CTMS Master; RTSM Master; eTMF Master; AnjuEPS eSource/site automation for Early Phase clinics; and TA Scan clinical intelligence for study planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniComm company profile →
BaseCase
HQ: Germany
Website
- Description: Provider of a cloud-based customer engagement platform for the life sciences, enabling pharmaceutical and medtech companies to engage payers, healthcare providers, and healthcare professionals with personalized, interactive mobile content. Offers a no-code content creation platform with compliance and KAM enablement, web-service integrations, R-powered analytics, a portal for compliant apps, branded toolkits, and interactive content creation services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BaseCase company profile →
Deep Genomics
HQ: Canada
Website
- Description: Provider of an AI platform that analyzes RNA biology, identifies novel targets, and evaluates therapeutic candidates; BigRNA, the first RNA foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates; and BigRNA+, which expands BigRNA to include more genetic mechanisms and diseases for broader therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Genomics company profile →
De Novo Software
HQ: United States
Website
- Description: Provider of FCS Express, the fastest-growing flow cytometry data analysis solution in the industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full De Novo Software company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synsight
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synsight
2.2 - Growth funds investing in similar companies to Synsight
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synsight
4.2 - Public trading comparable groups for Synsight
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →